The sodium/glucose cotransporter 2 inhibitor Empagliflozin inhibits long QT 3 late sodium currents in a mutation specific manner. - Lunsonga LC; Fatehi M; Long W; Barr AJ; Gruber B; Chattopadhyay A; Barakat K; Edwards AG; Light PE (Journal of molecular and cellular cardiology, 2025)